The role of Oxalobacter formigenes colonization in calcium oxalate stone disease

Kidney International

Volumn 83, Issue 6, 2013, Pages 1144-1149

  Siener, Roswitha ^a   Bangen, Ursula ^a   Sidhu, Harmeet ^b   Hönow, Ruth ^c   Von Unruh, Gerd ^a   Hesse, Albrecht ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Oxthera   (United States)

^c Federal Institute for Drugs and Medical Devices   (Germany)

Author keywords

Calcium; Colon; Diet; Oxalate; Urinary calculi; Urolithiasis

Indexed keywords

CALCIUM OXALATE; CARBON 13; OXALIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOOD LEVEL; CALCIUM OXALATE STONE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; INTESTINE ABSORPTION; MALE; OXALOBACTER FORMIGENES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK REDUCTION; URINALYSIS; URINARY EXCRETION;

EID: 84882268800     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.104     Document Type: Article

References (35)

1. Hesse A, Siener R. Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 1997; 15: 165-171.
2. Siener R, Schade N, Nicolay C et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 2005; 173: 1601-1605.
3. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001; 59: 270-276.
4. Hönow R, Hesse A. Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzymereactor. Food Chem 2002; 78: 511-521.
5. Siener R, Hönow R, Seidler A et al. Oxalate contents of species of the Polygonaceae, Amaranthaceae and Chenopodiaceae families. Food Chem 2006; 98: 220-224.
6. Siener R, Hönow R, Voss S et al. Oxalate content of cereals and cereal products. J Agr Food Chem 2006; 54: 3008-3011.
7. Hönow R, Gu KLR, Hesse A et al. Oxalate content of green tea of different origin, quality, preparation and time of harvest. Urol Res 2010; 38: 377-381.
8. Hesse A, Siener R, Heynck H et al. The influence of dietary factors on the risk of urinary stone formation. Scanning Microsc 1993; 7: 1119-1128.
9. Voss S, Hesse A, Zimmermann DJ et al. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [13C2]oxalate absorption test. J Urol 2006; 175: 1711-1715.
10. Allison MJ, Dawson KA, Mayberry WR et al. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 1985; 141: 1-7.
11. Sidhu H, Hoppe B, Hesse A et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 1998; 352: 1026-1029.
12. Duncan SH, Richardson AJ, Kaul P et al. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 2002; 68: 3841-3847.
13. Kelly JP, Curhan GC, Cave DR et al. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol 2011; 25: 673-679.
14. Kharlamb V, Schelker J, Francois F et al. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 2011; 25: 1781-1785.
15. Sidhu H, Schmidt ME, Cornelius JG et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 1999; 10: S334-S340.
16. Kumar R, Mukherjee M, Bhandari M et al. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 2002; 41: 318-322.
17. Troxel SA, Sidhu H, Kaul P et al. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 2003; 17: 173-176.
18. Kwak C, Kim HK, Kim EC et al. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 2003; 44: 475-481.
19. Mittal RD, Kumar R, Mittal B et al. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 2003; 12: 208-213.
20. Kaufman DW, Kelly JP, Curhan GC et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008; 19: 1197-1203.
21. Liebman M, Al-Wahsh IA. Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr 2011; 2: 254-260.
22. Lange JN, Wood KD, Wong H et al. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology 2012; 79: 1286-1289.
23. Siener R, Ebert D, Hesse A. Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res 2001; 29: 245-248.
24. Mikami K, Akakura K, Takei K et al. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 2003; 10: 293-296.
25. Knight J, Jiang J, Wood KD et al. Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Urology 2011; 78: 475.e9-475.e13.
26. Jiang J, Knight J, Easter LH et al. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol 2011; 186: 135-139.
27. Argenzio RA, Liacos JA, Allison MJ. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs. J Nutr 1988; 118: 787-792.
28. Hönow R, Simon A, Hesse A. Interference-free sample preparation for the determination of plasma oxalate analyzed by HPLC-ER: preliminary results from calcium oxalate stone-formers and non-stone-formers. Clin Chim Acta 2002; 318: 19-24.
29. Robijn S, Hoppe B, Vervaet BA et al. Hyperoxaluria: a gut-kidney axis? Kidney Int 2011; 80: 1146-1158.
30. Bergsland KJ, Zisman AL, Asplin JR et al. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol 2011; 300: F311-F318.
31. Hatch M, Cornelius J, Allison M et al. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 2006; 69: 691-698.
32. Hoppe B, Beck B, Gatter N et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type. Kidney Int 2006; 70: 1305-1311.
33. Hoppe B, Dittlich K, Fehrenbach H et al. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis 2011; 58: 453-455.
34. Hoppe B, Groothoff JW, Hulton SA et al. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 2011; 26: 3609-3615.
35. von Unruh GE, Voss S, Sauerbruch T et al. Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 2003; 169: 687-690.